MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
asset
$7,000K
Net cash provided by
investing activities
$7,000K
Net increase
(decrease) in cash, cash...
-$29,668K
Canceled cashflow
$7,000K
Net income (loss)
$29,821K
Stock-based compensation
expense
$5,255K
Prepaid expenses and
other current assets
-$1,896K
Non-cashlease expense
$622K
Depreciation expense
$391K
Amortization of debt discount
and issuance costs
$180K
Other noncurrent
assets
-$116K
Loss on impairment of
equity investment
$74K
Net cash used in
operating activities
-$33,543K
Canceled cashflow
$38,355K
Net cash provided by
(used in) financing...
-$3,125K
Non-cash revenue from
settlement of customer...
$53,737K
Gain on sale of asset
$11,737K
Accrued expenses and
other current...
-$3,328K
Accounts payable
-$2,110K
Operating lease liability
-$612K
Change in fair value of
cvr liability
$374K
Principal payments on
venture debt
-$3,125K
Back
Back
Cash Flow
source: myfinsight.com
Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB)